New dialysis needle aims to improve safety for kidney patients
NCT ID NCT05927532
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tested a new dialysis needle called the Argyle Safety Fistula Cannula with an anti-reflux valve. It was used in 40 adults with end-stage kidney failure who get dialysis three times a week for 12 weeks. The goal was to see if the needle is safe and works well for hemodialysis.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Argyle Safety Fistula Cannula with Anti-Reflux Valve (a specialized dialysis needle)
What this could lead to
If successful, this cannula could make dialysis sessions safer and more reliable for people with kidney failure.
What could go wrong
This is a small, early-stage study with only 40 participants and no comparison group, so results may not apply to everyone. The device is already on the market in some regions, so the novelty is limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END STAGE RENAL FAILURE ON DIALYSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
DaVita Columbus
Columbus, Georgia, 31904, United States
-
DaVita Hartford
Hartford, Connecticut, 06082, United States
-
DaVita Norfolk
Norfolk, Virginia, 23505, United States